DIANZANI, Chiara

DIANZANI, Chiara  

SCIENZA E TECNOLOGIA DEL FARMACO  

Mostra records
Risultati 1 - 20 di 191 (tempo di esecuzione: 0.031 secondi).
Titolo Data di pubblicazione Autore(i) File
3D advanced human melanoma models 2017 Sorrentino, R; Squarzanti, Df; Dianzani, C; Cavalli, R; Cassoni, P; Annaratone, L; Ribero, S; Russo, R; Senetta, R; Daga, M; Barrera, G; Azzimonti, B; Pizzimenti, S
3D advanced melanoma models 2016 Azzimonti, Barbara; Landini, Manuela Miriam; Sorrentino, Rita; Dianzani, Chiara; Cavalli, Roberta; Castellano, Isabella; Annaratone, Laura; Ribero, Simone; Russo, Rosalia; Senetta, Rebecca; Daga, Martina; Barrera, Giuseppina; Pizzimenti, Stefania
A mutation in caspase-9 decreases the expression of BAFFR and ICOS in patients with immunodeficiency and lymphoproliferation 2015 Clemente, N; Boggio, E.; Gigliotti, C.L.; Orilieri, E.; Cappellano, G.; Toth, E.; Valletti, P.A.; Santoro, C.; Quinti, I.; Pignata, C.; Notarangelo, L.D.; Dianzani, C.; Dianzani, I.; Ramenghi, U.; Dianzani, U.; Chiocchetti, A.
A preliminary in vitro and in vivo study of the effects of new anthraquinones on neutrophils and bone remodeling 2005 SAVARINO L; BENETTI D; BALDINI N; TARABUSI C; GRECO M; ALOISI R; FRASCARELLI S; FANTOZZI R; DIANZANI C; MIAN M
A preliminary in vitro and in vivo study of the effects of new anthraquinones on neutrophils and bone remodeling. 2005 Savarino, L.; Benetti, D.; Baldini, N.; Tarabusi, C.; Greco, M.; Aloisi, R.; Frascarelli, S.; Fantozzi, R.; Dianzani, C.; Mian, M.
Adenosine modulation of primed human neutrophils 1994 Dianzani C.; Brunelleschi S.; Viano I.; Fantozzi R.
Adhesion of polymorphonuclear cells to endothelial cells is physiologically inhibited by Gas6 1998 M. Gallicchio; C. Dianzani; M. Fontana; F. Capelli; M. Vidali; F. Bottarel; M. Bragardo; N. Surico; G. Garbarino; G. Saglio; U. Dianzani; R. Fantozzi; G.C. Avanzi
Ailanthone increases oxidative stress in CDDP-resistant ovarian and bladder cancer cells by inhibiting of Nrf2 and YAP expression through a post-translational mechanism 2020 Cucci M.A.; Grattarola M.; Dianzani C.; Damia G.; Ricci F.; Roetto A.; Trotta F.; Barrera G.; Pizzimenti S.
Ailanthone inhibits cell growth and migration of cisplatin resistant bladder cancer cells through down-regulation of Nrf2, YAP, and c-Myc expression 2019 Daga, Martina; Pizzimenti, Stefania*; Dianzani, Chiara; Cucci, Marie Angele; Cavalli, Roberta; Grattarola, Margherita; Ferrara, Benedetta; Scariot, Valentina; Trotta, Francesco; Barrera, Giuseppina
Albumin nanoformulations as an innovative solution to overcome doxorubicin chemoresistance 2021 Federica Bessone, Chiara Dianzani, Monica Argenziano, Luigi Cangemi, Rita Spagnolo, Federica Maione, Enrico Giraudo, Roberta Cavalli
Aldehydic lipid peroxidation products modulate the activity of human neutrophils 1995 Dianzani C; Parrini M; Ferrara C; Fantozzi R
Aldehydic lipid peroxidation products modulate the attivity of pro-inflammatory cell. 1994 Dianzani C.; Fantozzi R
Aminoglycoside excretion in a rat kidney model 1988 Viano I.; Silvestro L.; Dianzani C.; Giovannini L.; Bertelli A.A.E. Trombi L
Analyzing Cysteine Site Neighbors in Proteins to Reveal Dimethyl Fumarate Targets 2019 Rosa A.C.; Benetti E.; Gallicchio M.; Boscaro V.; Cangemi L.; Dianzani C.; Miglio G.
Antitumor activity of nanosponge-encapsulated camptotechin in human prostate tumors. 2010 Rosalba Minelli; Roberta Cavalli; Roberto Fantozzi; Chiara Dianzani; Piergiorgio Pettazzoni ; Roberto Pili
Antitumor activity of nanosponge-encapsulated camptothecin in human prostate tumors 2011 Minelli R; Cavalli R; Fantozzi R; Dianzani C; Pettazzoni P; Ellis L; Shen L; Pili R
Antitumor effect of nanosponge-encapsulated camptothecin in human prostate tumors 2012 Minelli R.; Cavalli R.; Occhipinti S.; Gigliotti C.L.; Fantozzi R.; Giovarelli M.; Dianzani U.; Dianzani C
Antitumor effect of nanosponges-encapsulated camptothecin in human prostate tumors 2012 Minelli R; Cavalli R; Occhipinti S; Gigliotti CL; Fantozzi R; Giovarelli M; Dianzani U; Dianzani C
AS601245, an anti-inflammatory JNK inhibitor, and clofibrate have a synergistic effect in inducing cell responses and in affecting the gene expression profile, in CaCo-2 colon cancer cells. 2012 Angelo Cerbone; Cristina Toaldo; Stefania Pizzimenti; Piergiorgio Pettazzoni; Chiara Dianzani; Rosalba Minelli; Eric Ciamporcero; Guglielmo Roma; Mario Umberto Dianzani; Roberto Canaparo; Carlo Ferretti; and Giuseppina Barrera
AS601245, an Anti-Inflammatory JNK Inhibitor, Strengthens the Effects of Clofibrate and Affects Gene Expression Profile, in CaCo-2 Colon Cancer Cells 2010 Barrera G; Cerbone A; Toaldo C; Pizzimenti S; Pettazzoni P; Dianzani C; Minelli R; Roma G; Dianzani MU; Ferretti C